Abiopharma

🔍 Rothrock Ray A. (Director)

Company: ROKU, INC (ROKU)

Report Date: 2026-06-11

Detailed Transactions and Holdings:

• Acquired 1,847 shares of Class A Common Stock (Direct)
  Date: 2026-06-11 | Code: M | equity_swap_involved: 0 | shares_owned_after: 44,784.00 | transaction_form_type: 4
• Sold 1,847 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-11 | Code: M | Exercise: 2026-06-11 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 1,027 shares of Restricted Stock Unit (Derivative)
  Date: 2026-06-11 | Code: A | equity_swap_involved: 0 | shares_owned_after: 1,027.00 | transaction_form_type: 4 | Footnotes: F1, F3, F3
• Acquired 1,745 shares of Stock Options (right to buy) at $119.64 per share (Derivative)
  Date: 2026-06-11 | Code: A | Expires: 2036-06-10 | equity_swap_involved: 0 | shares_owned_after: 1,745.00 | transaction_form_type: 4 | Footnotes: F4

Footnotes:

• F1: Each RSU represents a contingent right to receive one share of Class A Common Stock of the Issuer.
• F2: This RSU was granted on June 11, 2025 and vests in one installment on the earlier of the next annual meeting of the Issuer's stockholders or the first anniversary of the grant date.
• F3: This RSU was granted on June 11, 2026 and vests in one installment on the earlier of the next annual meeting of the Issuer's stockholders or the first anniversary of the grant date.
• F4: This option vests in 12 substantially equal monthly installments beginning on the one month anniversary of the grant date, provided that, to the extent the option is not vested on the date of the next annual meeting of the Issuer's stockholders following the grant date, the option will vest in full on the date of such annual meeting.
• REMARKS: Exhibit 24.1 - Power of Attorney and Exhibit 24.2 - Power of Attorney